Seoul St. Mary’s Hospital: Mustard Seed Growth Center to Showcase Achievements in Medical Technology Commercialization at KHF

Fourteen Teams Including Eleven from the First Commercialization Track to Participate
Showcasing Medical and Digital Healthcare Solutions
Exclusive Forum on August 20 Highlights Commercialization Cases and Hospital Technology Management

The Mustard Seed Growth Center, jointly operated by the Catholic Educational Foundation and Seoul St. Mary’s Hospital, will participate in ‘KHF 2026 (Korea International Hospital and Healthcare Tech Fair)’, held at COEX in Seoul from August 19 to 21, to showcase achievements in medical technology commercialization.

According to Seoul St. Mary’s Hospital on August 18, the Mustard Seed Growth Center has established a ‘commercialization track’ for the first time this year and selected 11 teams from among the 3rd to 5th Future Committee cohorts. From February to July, the center supported product enhancement, company matching, and market entry preparation. At this KHF, it will conduct its first official market validation.

Promotional Material for Mustard Seed Growth Center Commercialization Track 1st Cohort 'KHF 2026.' Seoul St. Mary’s Hospital

A total of 14 teams will participate in the event, including 11 teams from the commercialization track and 3 teams that have already completed commercialization. The technologies to be presented—discovered in clinical settings—include AI-based emergency room severity prediction, automated arterial blood sampling, personalized cough analysis, patient transport and safety management solutions, and a home hospice AI platform, as well as other medical and digital healthcare technologies.

On August 20 at 1 PM, the center will also host an exclusive forum at the COEX seminar room under the theme ‘Seeds of the Medical Field: How AI and Knowledge Platforms Cultivate the Forest of Innovation.’ There will be three sessions focusing on case studies of center operations and hospital technology management, with product demonstrations and one-on-one consultations also available at the booth.

As part of previous commercialization cases, OrthoCare—which developed the musculoskeletal digital therapeutics device ‘ANAPA’—and the XR Team, which created XR-based experimental animal dissection training content, will participate.

OrthoCare’s ANAPA is a digital therapeutic device that uses a smartphone camera to measure range of motion and muscle strength; it has been adopted by 21 hospitals within five months of launch. Currently, a confirmatory clinical trial involving orthopedic specialists from 12 university hospitals is underway, and the company has finalized regulatory strategies for both US FDA and European CE MDR clearance.

The XR Team has developed dissection training content implementing the 3R ethics principle for experimental animals using XR technology and secured patents in both Korea and the US. The AI and virtual convergence training platform ‘Metademy’ that utilizes this technology is currently offering 42 training content modules.

Kim Daejin, Head of the Mustard Seed Growth Center, remarked, “This event showcases how ideas from hospital staff have grown into products that address real challenges in medical settings and successfully reached the market. We will continue expanding partnerships with hospital stakeholders and investors as a medical and healthcare innovation incubator.”

This content was produced with the assistance of AI translation services.